SOADOR
SCLN

State of Alaska Department of Revenue’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

State of Alaska Department of Revenue’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,213
Closed -$114K – 1636
2017
Q3 		$114K Hold
10,213
– – 0.01% 1154
2017
Q2 		$112K Buy
10,213
+4,503
+79% +$45K 0.01% 1082
2017
Q1 		$55K Buy
5,710
+300
+6% +$3K ﹤0.01% 1100
2016
Q4 		$58K Buy
+5,410
New +$54.1K 0.01% 804

State of Alaska Department of Revenue's SCLN Position: Q4 2017 in Review

State of Alaska Department of Revenue sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 10,213 shares — an estimated $114K sold.

State of Alaska Department of Revenue first reported a position in SCLN in Q4 2016 and held it in 4 quarters. The position peaked at $114K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • State of Alaska Department of Revenue reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 10,213 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $114K.
  • State of Alaska Department of Revenue first reported a position in Sciclone Pharmaceuticals Inc in Q4 2016 and held it in 4 quarters.
  • State of Alaska Department of Revenue's Sciclone Pharmaceuticals Inc position peaked at $114K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on State of Alaska Department of Revenue's 13F filing for Q4 2017, filed 19 Jan 2018.